arabinofuranosyluracil has been researched along with Cancer of Ovary in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Howell, SB; King, ME; Pfeifle, CE | 1 |
Cleary, SM; Howell, SB; Kirmani, S; Mowry, J; Zimm, S | 1 |
Adachi, S; Hirooka, C; Ichijo, M; Kiyozuka, Y; Noda, T; Oku, M; Yamamoto, T | 1 |
3 other study(ies) available for arabinofuranosyluracil and Cancer of Ovary
Article | Year |
---|---|
Intraperitoneal cytosine arabinoside therapy in ovarian carcinoma.
Topics: Adult; Aged; Arabinofuranosyluracil; Cytarabine; Female; Humans; Injections, Intraperitoneal; Kinetics; Middle Aged; Ovarian Neoplasms; Peritoneal Dialysis; Tumor Stem Cell Assay | 1984 |
Extremely prolonged continuous intraperitoneal infusion of cytosine arabinoside.
Topics: Adult; Aged; Arabinofuranosyluracil; Ascitic Fluid; Colonic Neoplasms; Cytarabine; Female; Humans; Infusion Pumps, Implantable; Infusions, Parenteral; Leukopenia; Metabolic Clearance Rate; Middle Aged; Ovarian Neoplasms; Peritonitis; Thrombocytopenia; Time Factors | 1990 |
[Intraperitoneal (i.p.) chemotherapy in the management of ovarian cancer--pharmacokinetics and methods of sequential i.p. chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosyluracil; Carcinoma, Squamous Cell; Child; Cisplatin; Cystadenocarcinoma; Cytarabine; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Infusion Pumps; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Teratoma | 1990 |